Filter by
Selections
February 23, 2015
Arrowhead Begins Phase 1 Trial of ARC-AAT for Treatment of Liver Disease Associated with Alpha-1 Antitrypsin Deficiency
Read MoreFebruary 17, 2015
Arrowhead to Present at 2015 RBC Capital Markets’ Global Healthcare Conference
Read MoreDecember 29, 2014